SCHEMBL35489

SCHEMBL35489

CC[CH]OCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11211515 0.83 HSD17B10 (0.32)
SCHEMBL60677 0.81
SCHEMBL982731 0.79
SCHEMBL65918 0.78
SCHEMBL984576 0.77 THRB (0.42)
SCHEMBL982532 0.77 THRB (0.42)
SCHEMBL133829 0.77 THRB (0.42)
SCHEMBL982044 0.77 THRB (0.42)
SCHEMBL983446 0.77 THRB (0.42)
SCHEMBL134426 0.77 THRB (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 6002 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118354999-A Pyridazine-1 (6H) -6-oxo compound and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-07-16 CN claimed
WO-2024120457-A1 PYRROLO[3,2-D]PYRIMIDIN-4-ONE DERIVATIVE, AND PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF 深圳信立泰药业股份有限公司 2024-06-13 WO claimed
WO-2024114793-A1 SALT FORM AND CRYSTAL FORM OF UBIQUITINATION-SPECIFIC PROTEASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 杭州普济远成生物医药科技有限公司 2024-06-06 WO claimed
CN-118126046-A Substituted macrocyclic compound, and preparation method and application thereof 深圳信立泰药业股份有限公司 2024-06-04 CN claimed
CN-118121608-A Ubiquitin specific protease inhibitor salt form, ubiquitin specific protease inhibitor crystal form, preparation methods and application of ubiquitin specific protease inhibitor salt form and ubiquitin specific protease inhibitor crystal form 杭州普济远成生物医药科技有限公司 2024-06-04 CN claimed
US-20240166627-A1 Terpyridinedione compound or salt thereof, and preparation method and application thereof SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. (CN) 2024-05-23 US claimed
CN-117916246-A Ubiquitin specific protease inhibitor salt form, ubiquitin specific protease inhibitor crystal form, preparation methods and application of ubiquitin specific protease inhibitor salt form and ubiquitin specific protease inhibitor crystal form 杭州普济远成生物医药科技有限公司 2024-04-19 CN claimed
WO-2024051696-A1 COMPOUND FOR RNA CAPPING AND USE THEREOF 广州市恒诺康医药科技有限公司 2024-03-14 WO claimed
CN-117645642-A Compounds for RNA capping and uses thereof 广州市恒诺康医药科技有限公司 2024-03-05 CN claimed
CN-117567541-A Steroid cationic lipid compound, lipid nanoparticle, and preparation methods and applications thereof 中国科学技术大学 2024-02-20 CN claimed
US-4851405-A FUNGICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-07-25 US claimed
US-4800202-A FUNGICIDES, PESTICIDES BAYER AKTIENGESELLSCHAFT (DE) 1989-01-24 US claimed
EP-0289913-A2 Parasiticidal agent based on substituted aminomethyl heterocycles BAYER AG (DE) 1988-11-09 EP claimed
EP-0284952-A2 Substituted propylamines BAYER AG (DE) 1988-10-05 EP claimed
EP-0281842-A1 Aminomethyl-heterocycles BAYER AG (DE) 1988-09-14 EP claimed
EP-0278352-A2 Aminomethyl-tetrahydro-furanes BAYER AG (DE) 1988-08-17 EP claimed
EP-0278311-A1 2-Aminomethyl tetrahydrofuranes BAYER AG (DE) 1988-08-17 EP claimed
US-4053469-A BACTERICIDES SHIONOGI & CO., LTD. (JA) 1977-10-11 US claimed
US-4015012-A ANTHELMINTICS BAYER AKTIENGESELLSCHAFT (DT) 1977-03-29 US claimed
US-3970699-A 4-Acylaminophenylacetamidines and a method for their preparation BAYER AKTIENGESELLSCHAFT (DT) 1976-07-20 US claimed